Posts tagged “Duke”
Expression Analysis Strikes Duke Deal, Closing $1 Million in Angel Funding
Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.
Expression Analysis Strikes Deal with Duke, Closing $1 Million in Angel Funding
Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.
Expression Analysis Strikes Duke Collaboration, Closing $1 Million in Angel Funding
Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.
Expression Analysis Strikes Duke Collaboration, Closing $1 Million in Angel Funding by End of March
Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.
Sitting on $900 Million: After 2001 Bust, Southeast VCs Hoarding the Cash
Investors in Georgia, NC say they want to see more good ideas and a better economy to pump up their return on investment. 'Returns will continue to suffer in the short term,' says Intersouth's Mitch Mumma.
Hey Is Back in the Saddle at MDeverywhere, Taking Over as CEO
Company insists move to replace Alan Rubin is 'amicable', adds that Rubin 'will be resigning' in next few days. Hey plans aggressive growth for company he founded.
Shocker: Paradigm Terminates Founder and CEO John Ryals; He Calls It 'Power Play'
Company sites no reason for dismissal. Ryals mum on next steps but hints at litigation. Biotech community stunned by the decision announced late Monday.
Paradigm Genetics Terminates Founder, President and CEO John Ryals
No reason cited for Ryal's ouster. Stock price had been dropping. Ryals and other execs have been selling stock. And the company has said Ryals was essential to its success, insuring him for $2 million.
Blue Diamond Awards Highlight Best in Charlotte High-Tech
MobileHWY, V3 Systems Among Headliners at Charlotte Chamber's Information Technology Council Awards. Ten Companies Take Home Honors.
Heart Disease Is Initial Focus of Paradigm-Duke Collaboration; Salix Submits New Drug Application
Paradigm Genetics, Duke sign a multi-year agreement to study the biochemistry of cells looking for clues to new treatments for multiple illnesses. <b>Also: </b>Salix submits NDA for traveler's diarrhea treatment.
Adult Stem Cell Progress Seems To Bolster Fortunes of Three Local Firms
Researchers at Duke and the University of Minnesota report exciting findings in adult stem cell experiments. To three Triangle companies - StemCo., Artecel, and Incara - that's good news.
CED Chooses 28 N.C. Firms To Make Pitch at Venture 2002 Conference
Firms cover an array of life sciences, hardware, software, telecommunications and online services. Investors from across the Southeast are expected to attend. 'We get to see a whole lot of people at once,' executive from presenting company says.
Bridging the Gap Between Charlotte and RTP?
Can Charlotte, RTP, other parts of NC find common ground to help state succeed as a biotech leader? UNC-Charlotte, bolstered recently by a $2.25 million NIH grant, intends to be a player on its own.
VC Profile: Aurora's Co-Founders Aggressively Build $70 Million Fund in Just Three Years
Sweet spot for investments: Seed and early stage life-science and information technology deals in the Southeast. But Aurora will make deals elsewhere, as the record shows.
Scientists Must Address People's Ethical and Moral Concerns as Well as Desire for New Drugs, Experts
'Just because you're pursuing good science doesn't guarantee acceptance,' NCSU professor warns at Emerging Issues Forum. NC Biotech president calls for 'investment" in dealing with public's worries up front.




















